Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) FCF Margin (QoQ) (2009 - 2026)

Bio-Rad Laboratories (BIO) FCF Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -294.00
Mar 31, 2026 -399.00
Dec 31, 2025 352.00
Sep 30, 2025 279.00
Jun 30, 2025 -545.00
Mar 31, 2025 413.00
Dec 31, 2024 -681.00
Sep 30, 2024 1,033.00
Jun 30, 2024 381.00
Mar 31, 2024 -84.00
Dec 31, 2023 -280.00
Sep 30, 2023 -83.00
Jun 30, 2023 10.00
Mar 31, 2023 308.00
Dec 31, 2022 857.00
Sep 30, 2022 -764.00
Jun 30, 2022 272.00
Mar 31, 2022 -1,317.00
Dec 31, 2021 -1,055.00
Sep 30, 2021 787.00